# US 2023/0053759 A1 · Preparation of a pharmaceutical intermediate

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0053759 A1
- Document ID: US20230053759A1
- Status: Published application
- Kind: A1
- Application number: 17/811,888
- Filed: 2022-07-12
- Published: 2023-02-23
- Earliest claimed: 2021-07-15
- Assignees: Dipharma Francis S.R.L.
- Applicants: Dipharma Francis S.R.L.
- Inventors: Francesca Della Penna; Valeria Nori; Fabio Pesciaioli; Armando Carlone
- Web page: https://patentgrep.com/patent/US20230053759A1

## CPC

- C07C 45/46: Friedel-Crafts reactions
- C07C 45/65: by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups
- C07C 209/62: by cleaving carbon-to-nitrogen, sulfur-to-nitrogen, or phosphorus-to-nitrogen bonds, e.g. hydrolysis of amides, N-dealkylation of amines or quaternary ammonium compounds (C07C209/24 takes precedence)
- C07C 209/68: from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton
- C07C 209/78: from carbonyl compounds, e.g. from formaldehyde, and amines having amino groups bound to carbon atoms of six-membered aromatic rings, with formation of methylene-diarylamines
- C07C 213/00: Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C 249/08: by reaction of hydroxylamines with carbonyl compounds
- C07C 2601/16: the ring being unsaturated
- C07C 2603/32: Dibenzocycloheptenes; Hydrogenated dibenzocycloheptenes
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS

## Abstract

The present disclosure provides a new procedure for preparing a key intermediate for active pharmaceutical ingredients useful in the treatment of diseases related to the central nervous system.

## Claims

### Claim 1

A process for preparing a compound of formula (I)
comprising cyclizing the compound of formula (II)
in presence of a sulfonated styrene-divinylbenzene copolymer ion exchange resin.

### Claim 2 (depends on 1)

The process according to claim 1, wherein the process is carried out in a solvent.

### Claim 3 (depends on 2)

The process according to claim 2, wherein the solvent is an aprotic organic solvent having a boiling temperature between 0° C. and 160° C.

### Claim 4 (depends on 3)

The process according to claim 3, wherein the solvent is chosen from a linear or branched C4-C12 alkane, an aromatic hydrocarbon, a chlorinated solvent, an ether, a dipolar aprotic solvent, or a mixture of two or more of them.

### Claim 5 (depends on 4)

The process according to claim 4, wherein the solvent is chosen from hexane, heptane, cyclohexane, toluene, ortho-xylene, meta-xylene, para-xylene or a mixture of two or more of them.

### Claim 6 (depends on 1)

The process according to claim 1, wherein 100.0 moles to 0.001 moles of sulphonic acid groups of the sulfonated styrene-divinylbenzene copolymer are used per mole of compound of formula (II).

### Claim 7 (depends on 1)

The process according to claim 1, wherein 10 moles to 0.01 moles of sulphonic acid groups of the sulfonated styrene-divinylbenzene copolymer are used per mole of compound of formula (II).

### Claim 8 (depends on 1)

The process according to claim 1, wherein the temperature is between 0° C. and the reflux temperature of the reaction mixture.

### Claim 9 (depends on 1)

The process according to claim 1, wherein the temperature is between 20° C. and 150° C.

### Claim 10 (depends on 1)

The process according to claim 1, wherein the process is carried out by a continuous flow process or by a batch process.

### Claim 11 (depends on 1)

The process according to claim 1, comprising activating the compound of formula (II) to form a compound of formula (III)
wherein X is a halogen or a O—(C═O)—R group,
and wherein R is C1-C6 alkyl, C3-C8 cycloalkyl, C1-C6 alkoxy or —O—(C═O)-imidazolyl,
and then treating the compound of formula (III) with the sulfonated styrene-divinylbenzene copolymer ion exchange resin.

### Claim 12 (depends on 11)

The process according to claim 11, wherein X is chlorine.

### Claim 13 (depends on 11)

The process according to claim 11, wherein the process is carried out using from 5.0 moles to 0.3 moles of the activating agent per mole of the compound of formula (II).

### Claim 14 (depends on 1)

The process according to claim 1, further comprising preparing amitriptyline, nortriptyline or noxiptilin.

### Claim 15 (depends on 14)

The process according to claim 14, comprising preparing amitriptyline of formula (IV), or a pharmaceutically acceptable salt thereof,
comprising reacting the compound of formula (I)
with 3-dimethylaminopropylmagnesium chloride of formula (V)
to give the corresponding tertiary alcohol of formula (VI)
and subsequently treating the compound of formula (VI) with an acid.

### Claim 16 (depends on 15)

The process according to claim 15, further comprising the preparation of nortriptyline of formula (VII) or a pharmaceutically acceptable salt thereof,
comprising reacting amitriptyline of formula (IV), or a pharmaceutically acceptable salt thereof,
with methyl iodide and then methylamine; or
demethylating amitriptyline of formula (IV), or a pharmaceutically acceptable salt thereof,
with ethyl chloroformiate and a base.

### Claim 17 (depends on 14)

The process according to claim 14, comprising the preparation of nortriptyline of formula (VII) or a pharmaceutically acceptable salt thereof,
comprising reacting the compound of formula (I)
with 3-methylaminopropylmagnesium chloride of formula (VIII)
to give the corresponding tertiary alcohol of formula (IX)
and subsequently treating the compound of formula (IX) with an acid.

### Claim 18 (depends on 14)

The process according to claim 14, comprising preparing noxiptiline of formula (X), or a pharmaceutically acceptable salt thereof,
by reacting the compound of formula (I) first with hydroxylamine, or a salt thereof, and then with 3-chloro-N,N-dimethyl-propan-1-amine.
